Indian healthcare providers are scaling artificial intelligence from controlled pilots into live operational use cases, with early deployments focused on reducing administrative burdens on clinicians, according to a report released on Tuesday, 8 September by Bain & Company and HealthQuad. The findings signal a measurable shift in how hospitals and health systems are engaging with AI — though meaningful scale remains concentrated in workflow automation rather than clinical decision-making.

Enabling Conditions Strengthening

The report credits several converging factors for the improved environment: government initiatives, rising Electronic Medical Record (EMR) penetration, deployment of private capital, a thriving start-up ecosystem, and growing clinician acceptance. Together, these are building the infrastructure necessary for AI to move beyond proof-of-concept stages.

However, the report cautions that most providers are still operating within controlled testing environments, with meaningful scale limited to operational and administrative workflows rather than frontline clinical care.

EMR Gap Remains a Structural Constraint

EMR adoption in India stands at nearly 35% — significantly below levels seen in the United States and the United Kingdom — and is concentrated among larger urban hospital chains. The majority of small- and mid-sized hospitals continue to rely heavily on paper-based records, a gap that constrains how broadly AI tools can be deployed and trained on local clinical data.

India's regulatory framework for adaptive and autonomous clinical AI is also still evolving, particularly around accountability, data governance, and clinical validation standards, the report noted.

Talent and Start-Up Momentum

India possesses deep AI capabilities, but much of that talent is currently directed toward global markets rather than domestic healthcare applications, according to the report. Despite this, Indian start-ups are already building solutions across the full patient journey — spanning pre-visit access, diagnostics, inpatient treatment, and post-discharge care.

Dhruv Sukhrani, Head of Bain & Company's Healthcare & Life Sciences practice in India, said: 'AI adoption in Indian healthcare is still early, but the conditions for it to scale are strengthening quickly.' He added: 'The technology itself has advanced significantly; the harder question now is how providers redesign workflows, manage change and build trust among doctors and nurses.'

Frontier Models and Falling Costs

The report highlights that frontier AI models now match or outperform pre-licensed medical professionals in some controlled clinical reasoning tests. Critically, the cost of frontier AI models has fallen by approximately 92% since 2023, making these capabilities increasingly accessible to providers across budget tiers.

Significant headroom for deeper AI integration was identified in areas including remote patient monitoring, operating theatre optimisation, ICU management, and post-discharge chronic disease management — segments where AI could reduce both clinical load and patient readmission rates.

What Comes Next

The path from pilot to scale will hinge on workflow redesign, change management, and clinician trust-building — challenges the report frames as more complex than the technology itself. As regulatory clarity improves and EMR penetration deepens beyond urban chains, the conditions for broader clinical AI deployment in India are expected to strengthen further in the near term.